Abstract
Dopaminergic pathways appear to be involved in many brain functions including motoric, mental and emotional states. Dopamine is also associated with controlling pituitary prolactin and α melanocyte-stimulating hormone release. Dopamine receptors have been divided into D-l and D-2 subclasses according to their relationship to the adenylate cyclase system and their affinity for dopaminergic agonists and antagonists (reviewed in Seeman, 1980; Niznik, 1987). The D-l receptor stimulates adenylate cyclase and is virtually insensitive to substituted benzamide neuroleptics, whereas the D-2 receptor inhibits adenylate cyclase activity and has picomolar or nanomolar affinities for all neuroleptics. The D-2 receptor has been solubilized from membranes of pituitary gland and striatum by use of various detergents, and its pharmacology is well defined. This receptor is a glycoprotein as indicated by its specific adsorption to and elution from wheat germ agglutinin-Sepharose. Photoaffinity labeling of the D-2 dopamine receptor has indicated that, in a variety of mammalian tissues and species, a 92–94 kDa polypeptide is probably the ligand binding unit of the receptor (Lew et al.,1985; Amlaiky and Caron, 1986; Kanety and Fuchs, 1988). In order to elucidate the molecular mechanisms by which dopaminergic signal transduction correlates with dopaminergic functions, it is essential to isolate and fully characterize this receptor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amlaiky N,Caxon MG (1986) J Neurochem 47: 196–204.
Cote TE, Frey EA, Sekura RD (1984) J Biol Chem 259: 8693–8698.
Delebeke D, Dannies PS (1985) Endocrinology 117: 439–446.
Elazar Z, Kanety H, David C, Fuchs S (1988a) Biochen Biophys Res Coninun 156: 602–609.
Elazar Z, Siegel G, David C, Kanety H, Fuchs S (1988b) Soc Neurosci Abst 3778. 2.
Harris-Warrick EM, Hammond C, Paupardin-Tritsch D, Hcmburger V, Rout B, Bockaert J, Gerschonteld HM (1988) Neuron 1: 27–32.
Judd AM, Koike K, Schettini G, Longin IS, Hewelett EL, Yosumoto T, MacLeod RM (1985) Endocrinology 117: 1215–1221.
Kanety H, Fuchs S (1988) Biochem Biophys Res Conrnun 155: 930–936.
Kanety H, Schreiber M, Elazar Z, Fuchs S (1988) J Neuroiimrunol 18: 25–36.
Katada T, Oinuma M, Kusakabe K, Ui M (1987) FEBS Lett 213: 353–358.
Lew JY, Meiler E, Goldstein M (1985) Eur J Pharmacol 113: 145–146.
Niznik HB (1987) Mol Cell Endocrinol 54: 1–22
Pizzi M, D’Agostini F, DaPrada M, Spano PF, Haefely WE (1987) Eur J Pharmacol 136: 236–269.
Seeman P (1980) Pharmacol Rev 32: 229–313.
Seaman P, Watanabe M, Grigoradis D, Tedesco JL, George SR, Svensson V, Nilsson JLG, Neumeyer JL (1985) Mol Pharmacol 28: 391–399.
Senogles SE, Benovic JL, Amlaiky N, Unson C, Milligan G, Vinitsky R, Spiegel AM, Caron MG (1987) J Biol Chem 262: 4860–4867.
Sibley DR, Creese I (1983) J Biol Chem 258: 4957–4965.
Simmonds SH, Strange PG, Hall AW, Taylor RJK (1986) Biochem Pharmacol 35: 731–735.
Stoof JC, Werkman TR, Lodder JC, De Vlieger ThA (1986) Trends Pharmacol Sei 7: 7–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Elazar, Z., Siegel, G., Kanety, H., Fuchs, S. (1989). Purification of the D-2 Dopamine Receptor and Characterization of Its Signal Transduction Mechanism. In: Evangelopoulos, A.E., Changeux, J.P., Packer, L., Sotiroudis, T.G., Wirtz, K.W.A. (eds) Receptors, Membrane Transport and Signal Transduction. NATO ASI Series, vol 29. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74200-2_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-74200-2_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74202-6
Online ISBN: 978-3-642-74200-2
eBook Packages: Springer Book Archive